This suggests the potential role of IGF-1 as a novel therapeutic target, also in combination with insulin, in therapeutic strategies to repair impaired glucose metabolism in the treatment of dementia in sporadic Alzheimer’s disease and type 2 diabetes. Here, IGF1 is linked to dementia.